I am currently enrolled in the study and unable to comment on what I perceive to be the results. The study is to determine whether a drug will lower LP(a) numbers. The drug is in its infancy, not yet approved by the FDA. It is "double blind" which means that no one, including the lead doctor knows the study results. I highly recommend that you research medical studies being conducted in your area. They can be a very valuable health tool.